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In Brief
Classical Ly6C+ monocytes have been
identified as important players in various
inflammatory conditions; however, little
is known about the role of the nonclas-
sical Ly6C monocytes. Here, Misharin
et al. report that nonclassical Ly6C
monocytes are crucial for the initiation of
joint inflammation in a mouse model of
rheumatoid arthritis. This study also un-
veils phenotypical and ontological het-
erogeneity of the synovial macrophages
in steady state and arthritis and reveals
how macrophage polarization controls
progression and resolution of the
disease.
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Different subsets and/or polarized phenotypes of
monocytes andmacrophagesmay play distinct roles
during the development and resolution of inflamma-
tion. Here, we demonstrate in a murine model of
rheumatoid arthritis that nonclassical Ly6C mono-
cytes are required for the initiation and progression
of sterile joint inflammation. Moreover, nonclassical
Ly6C monocytes differentiate into inflammatory
macrophages (M1), which drive disease pathogen-
esis and display plasticity during the resolution
phase. During the development of arthritis, these
cells polarize toward an alternatively activated
phenotype (M2), promoting the resolution of joint
inflammation. The influx of Ly6C monocytes and
their subsequent classical and then alternative acti-
vation occurs without changes in synovial tissue-
resident macrophages, which express markers of
M2 polarization throughout the course of the arthritis
and attenuate joint inflammation during the initiation
phase. These data suggest that circulating Ly6C
monocytes recruited to the joint upon injury orches-
trate the development and resolution of autoimmune
joint inflammation.INTRODUCTION
Our understanding of the mononuclear phagocyte system in the
initiation and resolution of inflammation has been significantly
revised over the past years, in part due to discovery of heteroge-
neity of peripheral blood monocytes and tissue macrophages
(Davies et al., 2013a; Ginhoux and Jung, 2014). Peripheral blood
monocytes are subclassified into three different populations
based on expression of cell-surface molecules and functions
(Ziegler-Heitbrock et al., 2010). In humans, these populationsCcorrespond to CD14++CD16 (classical monocytes), CD14++
CD16+ (intermediate monocytes), and CD14+CD16++ (nonclas-
sical monocytes), and in mice, the equivalent populations
are Ly6C+CD62L+CD43CCR2+ (classical monocytes), Ly6Cint
CD62LCD43+CCR2 (intermediate monocytes), and Ly6C
CD62LCD43+CCR2 (nonclassical monocytes). An emerging
literature suggests a previously unrecognized role for nonclas-
sical Ly6C monocytes during tissue injury. These cells patrol
the luminal side of the endothelium and extravasate in response
to both septic and aseptic tissue injury (Auffray et al., 2007), and
recent work suggests that these cells may serve as precursors
for alternatively activated macrophages (Auffray et al., 2009;
Nahrendorf et al., 2007), playing a protective or anti-inflamma-
tory role during tissue injury (Hamers et al., 2012; Hanna et al.,
2012). However, the relative contribution of classical Ly6C+
compared with nonclassical Ly6C monocytes to tissue injury
and repair is incompletely understood.
Another major component of themononuclear phagocyte sys-
tem is represented by tissue-resident macrophages. Classic
work by van Furth identified bone-marrow-derived monocytes
as precursors to tissue macrophages (van Furth and Cohn,
1968). However, recent studies showed that many tissue macro-
phages such as microglia in the brain, peritoneal macrophages,
and Kupffer cells in the liver, originate from yolk sac or fetal liver
progenitors (Ginhoux et al., 2010; Schulz et al., 2012; Yona et al.,
2013). These tissue-resident macrophages are long lived and
self-renewing via in situ proliferation, even in the absence of
recruitment of circulating monocytes (Davies et al., 2011;
Hashimoto et al., 2013; Jenkins et al., 2011), and have a gene-
expression profile specific to their anatomical localization and
microenvironment (Gautier et al., 2012). In adult animals, the
macrophage population in the lung, peritoneal cavity, and spleen
is more heterogeneous, with the addition of bone-marrow-
derived macrophages during steady-state and inflammatory
conditions (Davies et al., 2013b; Yona et al., 2013). The pro-
and anti-inflammatory properties of tissue-resident macro-
phages have been primarily studied as a single population in
the context of inflammation caused by microbes or parasites
(Cailhier et al., 2006; Davies et al., 2011; Jenkins et al., 2011;ell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 591
Maus et al., 2002). Moreover, the roles of tissue-resident macro-
phages during sterile inflammation are unknown and the relative
contributions of tissue-resident or monocyte-derived macro-
phages in any models of inflammation are largely unexplored.
Both tissue-resident and bone-marrow-derived macrophages
exhibit significant functional heterogeneity and may differentiate
or be polarized into one of twomainmacrophage subtypes: clas-
sically activated, M1 (proinflammatory), and alternatively acti-
vated, M2 (anti-inflammatory/resolution phase), macrophages
(Lech and Anders, 2013; Sica and Mantovani, 2012). Whereas
some studies suggest that alternatively, anti-inflammatory mac-
rophages may originate from a new wave of monocytes entering
into tissues during the resolution of inflammation (Nahrendorf
et al., 2007; Shechter et al., 2009, 2013), it is still not known if,
during disease pathogenesis, bone-marrow-derived classically
activated macrophages can exhibit plasticity and switch their
phenotype toward an alternatively activated one in situ.
Rheumatoid arthritis (RA) is a chronic autoimmune disease
affecting up to 1% of the world’s population (Helmick et al.,
2008), which makes it one of the most prevalent autoimmune
conditions. During RA, the dysregulation of the immune system
leads to destruction and deformation of the joint, resulting in
chronic pain, severe disability, and increased mortality. Circu-
lating monocytes in patients with RA are known to be activated
(Kawanaka et al., 2002; Kinne et al., 2007; Stuhlmu¨ller et al.,
2000; Torsteinsdo´ttir et al., 1999), and the number of macro-
phages in the synovium correlates with joint damage (Mulherin
et al., 1996) and clinical response to therapy (Haringman et al.,
2005). Murine models of RA represent a clinically relevant sys-
tem for deciphering the role of monocytes and macrophages in
the pathogenesis of sterile chronic autoimmune inflammation
(Vincent et al., 2012).
Here, we used a mouse model of immune-complex, sterile, in-
flammatory arthritis to uncover novel roles for monocyte subsets
and macrophages during distinct phases of disease develop-
ment. We demonstrate that circulating Ly6C monocytes are
recruited to the joint during the effector phase of arthritis and
differentiate into classically activated macrophages, which drive
the development of the joint pathology. However, as the arthritis
progresses, these same classically activated macrophages
change from a classically to an alternatively activated pheno-
type, which is necessary for the resolution of joint inflammation.
This remarkable influx of Ly6C monocytes and their dramatic
changes in polarization occurred without significant changes in
the number or phenotype of tissue-resident synovial macro-
phages. These findings suggest a new paradigm for understand-
ing the pathogenesis of RA, in which nonclassical monocytes
recruited to the joint exhibit remarkable phenotypic plasticity
over the course of arthritis, promoting first tissue injury and
then repair, overwhelming the constitutive anti-inflammatory
effects of the tissue-resident macrophages.
RESULTS
Differential Role of Monocyte Subsets in the Initiation of
Inflammatory Arthritis
The temporal changes in monocyte populations in murine
models of autoimmune arthritis and their contribution to impor-592 Cell Reports 9, 591–604, October 23, 2014 ª2014 The Authorstant disease phenotypes are still unknown. Here, we used a
murine model of sterile inflammatory arthritis (K/BxN serum-
transfer-induced arthritis [STIA]), which models the effector
phase of human RA; is independent of the adaptive immune
response; and consists of initiation, propagation, and resolution
phases (Monach et al., 2008). To depletemonocytes, we injected
clodronate-loaded liposomes intravenously 24 hr prior to the in-
duction of arthritis. Virtually all monocytes in the peripheral blood
and the red pulp macrophages in spleen were depleted for 48–
72 hr following the clodronate-loaded liposome treatment,
whereas the number of circulating neutrophils and synovial mac-
rophages was unchanged (Figure S1A). Monocyte depletion
completely prevented the development of STIA (Figure 1A) and
suppressed the recruitment of neutrophils to the joints (Fig-
ure S1B). Additionally, treatment with clodronate-loaded lipo-
somes at days 3 and 5 of STIA led to an abrupt end to the
development of STIA (Figure 1B). Because recent studies sug-
gested that the splenic pool of monocytes may also contribute
to acute inflammation, we splenectomized mice and showed
that there was no difference in ankle swelling or clinical scores
between the groups following the induction of STIA (Figure S1C).
To address the contribution of Ly6C+ monocytes to the initia-
tion and development of STIA, we depleted classical Ly6C+
monocytes using anti-CCR2 antibody. Whereas Ly6C+ mono-
cytes were dramatically reduced in the peripheral blood and
spleen following injection of anti-CCR2 antibody (Figure S1D),
the induction and development of STIA occurred normally (Fig-
ure S1E). Similarly, CCR2/ mice, which lack CCR2 on both
classical and nonclassical monocytes, were able to develop
STIA and recruit both neutrophils andmacrophages into the joint
(Figure S1F).
Because tools for selective depletion of nonclassical Ly6C
monocytes are not available, we developed approaches to
investigate the role of this population in the initiation of STIA.
First, we depleted monocytes using clodronate-loaded lipo-
somes, and STIA was induced at different stages of monocyte
subset recovery. Whereas nonclassical Ly6C monocytes failed
to recover even 7 days after injection of clodronate-loaded lipo-
somes, the total number of monocytes and neutrophils were
similar to controls at 7 days following the injection of clodro-
nate-loaded liposomes (Figures 1C and S1G). The absence of
Ly6C monocytes was also associated with an inability to
develop STIA (Figure 1D). Next, we treated mice with clodro-
nate-loaded liposomes 2 days prior to the initiation of arthritis,
and classical Ly6C+ or nonclassical Ly6C monocytes isolated
from bonemarrow were adoptively transferred immediately after
initiation of STIA. Mice that received Ly6C monocytes devel-
oped STIA at the same rate as control-treated animals (Fig-
ure 1E); however, mice that received Ly6C+monocytes exhibited
a marked delay in the development of STIA. These results likely
reflect the conversion of classical Ly6C+ monocytes into
nonclassical Ly6C monocytes after adoptive transfer (Yona
et al., 2013) or recovery of the depleted monocyte pool.
The Normal Adult Mouse Joint Contains Heterogeneous
Population of Tissue-Resident Macrophages
To further explore the role of Ly6C nonclassical monocyte
subsets in the development of inflammatory arthritis, we first
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Figure 1. Role of Monocytes in the Initiation and Development of STIA
(A) Depletion of monocytes using clodronate-loaded liposomes prevents initiation and development of STIA (n = 5). Orange arrows indicate injection of K/BxN
serum; black and red—PBS and clodronate-loaded liposomes, correspondingly.
(B) Depletion of monocytes during development of STIA (n = 4) leads to its abrupt ending. Mice were treated with clodronate-loaded liposomes at indicated time
points. Orange arrows indicate injection of K/BxN serum; black, blue, and red—PBS and clodronate-loaded liposomes, correspondingly.
(C and D) Absence of Ly6Cmonocytes prevents STIA.Monocytes were depleted using clodronate-loaded liposomes. (C) Representative contour plots gated on
CD45+CD115+CD11b+ blood cells (numbers represent percentages of the parent population). (D) Representative arthritis scores (n = 4).
(E) Adoptive transfer of Ly6C monocytes restores STIA. Monocytes were depleted with clodronate-loaded liposomes (red arrows) and 48 hr later 1 3 106
classical Ly6C+ (n = 4; gray arrow) or 0.53 106 nonclassical Ly6C (n = 2; blue arrow) monocytes sorted from bone marrow or PBS (control) were transferred via
intravenous injection, immediately following injection of K/BxN serum (orange arrows) to induce STIA. Another cohort of control mice was treated with PBS-
loaded liposomes (n = 4; black arrow).
All data are represented as mean ± SEM. Differences between groups were compared using two-way ANOVA for repeated measurements with Bonferroni
posttest; *p < 0.05; **p < 0.01; ***p < 0.001.examined the cellular composition of the murine joint in unchal-
lenged, normal wild-type mice using multiparameter flow
cytometry (Figure 2A). After excluding doublets, dead cells,
and nonhematopoietic cells, we identified myeloid cells as
CD11b+ and then excluded eosinophils (Siglec F+), neutrophils
(Ly6G+), and CD11b+ dendritic cells (DCs) (CD11b+CD11chigh
MHC II+CD64). We then subdivided the remaining CD11b+ cells
into Ly6C+CD11b+CD11cF4/80lowCD64int cells (referred as
Ly6C+CD64int cells) and CD11b+CD11cintF4/80+CD64+ cells
(macrophages). We further subclassified the macrophage
population as major histocompatibility complex (MHC) II+ or
MHC II, with the majority being MHC II macrophages (80%–
85%). Cytospin analysis (Figure 2B) revealed that MHC II
macrophages were smaller (10.0 ± 1.8 mM versus 8.9 ±
1.8 mM, correspondingly) and had more condensed chromatin
in the nuclei and more granular cytoplasm as compared to
MHC II+ macrophages, which had brighter nuclei and large
vacuoles in the cytoplasm. Additionally, both populations of
macrophages had similar surface expression of classic
macrophage markers, receptors involved in phagocytosis,
and uptake of apoptotic bodies with the exception of Tim-4
and CX3CR1 (Figure S2A). Immunofluorescent microscopy
confirmed that the MHC II+ and MHC II macrophages were
located within the synovial lining (Figure S2B). Further, human
synovial CD68+ macrophages obtained from synovial biopsies
in healthy volunteers or patients with RA were also heteroge-Cneous with respect to HLA-DR and CD163 expression
(Figure S2C).
To define the contribution of bone-marrow-derivedmonocytes
to the persistence of Ly6C+CD64int cells and MHC II and MHC
II+ synovial macrophages, we generated bone marrow chimeras
by irradiating CD45.1 hosts and transferring CD45.2 bone
marrow cells. Almost 80% of the MHC II synovial macrophages
were recipient origin even 2 months posttransfer (Figure 2C).
These data suggest that this population was radioresistant and
long lived and does not require a contribution from circulating
monocytes. In contrast, Ly6C+CD64int cells and MHC II+ macro-
phages were rapidly replaced by donor cells, similar to other
bone-marrow-derived macrophages, such as pulmonary inter-
stitial macrophages, small peritoneal macrophages, and splenic
monocytes (Figure S2D).We then analyzed ankles fromCCR2/
mice, which have a decreased number of monocytes in the
circulation. In agreement with the bone marrow chimera data,
CCR2/ mice had reduced numbers of Ly6C+CD64int cells,
CD11b+ DC, and MHC II+ macrophages, whereas the numbers
of MHC II macrophages were not affected (Figure S2E). The
number of synovial MHC II, but not MHC II+, macrophages
was dramatically decreased in the ankle joint (Figure 2D) from
mice that lack macrophage colony stimulating factor (M-CSF)
(Csf1op/Csf1op). Because previous studies have suggested that
M-CSF-responsive macrophages are derived from the yolk sac
or fetal progenitors (Ginhoux et al., 2010; Ginhoux and Jung,ell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 593
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Figure 2. Characterization of Synovial Macrophages under Steady-State Conditions in the Mouse Joint
(A) Flow cytometry analysis of a mouse joint during steady-state conditions. Numbers on the contour plots represent percentages of CD45+ cells.
(B) Photomicrographs of sorted MHC II+ and MHC II macrophages. The scale bar represents 5 mm.
(C) MHC II macrophages exhibit radioresistance and do not require input from bone marrow. Bone marrow transfer (n = 4 per time point) was performed as
described in the Experimental Procedures.
(D) Left: number of MHC II macrophages was dramatically reduced in the synovium of Cfs1op/op mice (n = 4). Right: representative contour plots showing
decrease of MHC II macrophages in the synovium. Numbers on the contour plots represent percentages of the parent population (macrophages).2014; Lichanska et al., 1999), these data suggest that, under
steady-state conditions, majority MHC II macrophages repre-
sent true tissue-resident macrophages, whereas most of the
MHC II+ synovial macrophages originate from bone marrow.
Furthermore, as the host’s Ly6C+CD64int cells were completely
replaced in the bone marrow chimeras, decreased in CCR2/
mice, and unaffected by the intravenous injection of clodro-
nate-loaded liposomes in wild-type (WT) mice, the Ly6C+CD64int
cells likely represent classical Ly6C+ monocytes, which extrava-
sated into tissues for surveillance (Jakubzick et al., 2013).
Peripheral Blood Monocytes Give Rise to Recruited
Macrophages during STIA
To better understand the contribution of monocytes throughout
the initiation, sustainment, and remission phases of STIA, we594 Cell Reports 9, 591–604, October 23, 2014 ª2014 The Authorsanalyzed the cellular composition of mouse ankles during the
course of STIA. All populations of myeloid cells expanded during
the initiation and propagation phases of STIA (Figure 3A). Neu-
trophils were the predominant cell subset during the peak of
STIA; however, their number rapidly declined during the resolu-
tion phase. Macrophage populations also changed over the
course of STIA. The MHC II+ subset prevailed during the propa-
gation phase, whereas the MHC II subset became the predom-
inant cell type during the resolution phase (Figure 3A). We then
focused on the early events of STIA (Figure S3A) and found an
increase in the number of MHC II+ macrophages first evident
at day 2 followed by an increase in the number of neutrophils
at day 3. These data indicate that the influx of monocytes and
their differentiation into macrophages precedes the recruitment
of neutrophils.
AC
D
B
Figure 3. Origin of Inflammatory Macrophages in the Arthritic Joint
(A) Dynamics of the individual cell subsets in the synovium during the course of STIA (n = 4).
(B) Analysis of EdU incorporation during the course of STIA. Arthritis was induced in bonemarrow chimeraswith shielded ankles as described in the Supplemental
Experimental Procedures section.
(C) Nonclassical Ly6C monocytes were labeled as described in the Experimental Procedures section. Representative contour plots are shown and numbers
represent percentages of monocytes.
(D) Nonclassical Ly6C monocytes are recruited to the arthritic joint and give rise to both MHC II+ and MHC II macrophages. Data are represented as
mean ± SEM.To unravel the relationships between the monocyte/macro-
phage subsets in the arthritic joint (blood monocytes, tissue-
resident macrophages, and inflammatory macrophages), we
performed a series of cell-labeling studies. To discriminate be-
tween tissue-resident (CD45.2) and recruited cells (CD45.1), we
generated bone marrow chimeras (CD45.1/CD45.2), but this
time, the ankles were shielded during irradiation (see Supple-
mental Experimental Procedures). Mice were then pulsed with
a single injection of 5-ethynyl-20-deoxyuridine (EdU) during
different stages of STIA (D-1, D2, D6, and D9), and incorporation
of EdU into donor cells (CD45.1) and host tissue-resident macro-
phages (CD45.2) was analyzed 24 hr later (D0, D3, D7, and D10;
Figure 3B). Within this time frame, only classical Ly6C+ mono-
cyteswere labeled in peripheral blood (Figure S3B). The percent-
age of EdU+Ly6C+CD64int cells (CD45.1) was similar to
circulating monocytes (CD45.1; Figure 3B). The percent of
EdU+ MHC II+ bone-marrow-derived macrophages (CD45.1)
washigher compared toEdU+MHC IImacrophages (Figure 3B).
After 48 hr (D2 of STIA), the percent EdU+ donor monocytes
(CD45.1) and Ly6C+CD64int CD45.1 cells decreased, whereas
the percent of EdU+ bone-marrow-derived macrophages
(CD45.1) reciprocally increased (Figure S3C). We then investi-
gatedwhether local proliferation of tissue-residentmacrophages
contributes to the increased number of macrophages duringCSTIA. Tissue-resident macrophages (CD45.2) exhibited low
levels of proliferation in the steady state (D0; 1.47% ± 0.51%),
which increased during the peak of arthritis (day 7; 3.10% ±
0.54%; p = 0.0198) and returned to baseline during the resolution
of STIA (day 10; 1.68%± 1.49%; p=0.82). However, despite their
ability to proliferate, the total number of tissue-resident macro-
phages (CD45.2) did not changeduring the course of STIA.More-
over, the ratio of recruited macrophages to tissue-resident
macrophages ranged between 7:1 and 20:1 during STIA (Fig-
ure S3D). Taken together, these data suggest that monocyte
recruitment and not local proliferation of tissue-resident macro-
phages contributes to increased number of macrophages during
STIA and that the overwhelming majority of macrophages in the
joint are derived from monocytes that extravasate during STIA.
Nonclassical Ly6C Monocytes Preferentially Give Rise
to MHC II Macrophages during STIA
Because our data indicate that nonclassical Ly6C monocytes
are required for STIA (Figures 1C and 1D), we examined whether
they are recruited into arthritic joint. We labeled Ly6C mono-
cytes (Figure 3C) and tracked their fate upon induction of STIA
(Figure 3D). There were no labeled Ly6C monocytes in the joint
in the nonarthritic mouse 3 days postlabeling (T = 0). In contrast,
the labeled Ly6C monocytes entered into arthritic joint andell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 595
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Figure 4. Role of Tissue-Resident Macro-
phages in the Initiation of STIA
(A) Local injection of DT depletes donor-derived
macrophages in CD11b-DTR/CD45.1 bone
marrow chimeric mice. Representative contour
plots gated on macrophages are shown (numbers
indicate percentages of the parent population).
(B) Depletion of MHC II+ macrophages does not
affect initiation and development of STIA (n = 5).
(C) Local injection of DT depletes host macro-
phages in CD45.1/CD11b-DTR bone marrow
chimeric mice and does not affect donor-derived
macrophages. Representative contour plots gated
on macrophages are shown (numbers indicate
percentages of the parent population).
(D) Depletion of MHC II macrophages accelerate
development of STIA (n = 10). Data are repre-
sented as mean ± SEM. Differences between
groups were compared using two-way ANOVA for
repeated measurements with Bonferroni posttest;
*p < 0.05; **p < 0.01; ***p < 0.001.
(E) Phagocytosis of high-molecular-weight TRITC-
labeled dextran by subpopulations ofmyeloid cells
in the naive mouse joint. Representative histo-
grams are shown.developed into both MHC II (77%) and MHC II+ (22%) synovial
macrophages during STIA (Figure 3D). These data indicate that
nonclassical Ly6Cmonocytes give rise to inflammatory macro-
phages in the context of STIA. To determine fate of synovial mac-
rophages during STIA, we adoptively transferred MHC II+ and
MHC II synovial macrophages sorted from ankles of day 3
STIA Cx3cr1gfp/+ mice into the periarticular space of day 3
STIA CD45.1 mice (Figures S3E and S3F). Synovial macro-
phages exhibited plasticity in terms of MHC II expression, as
50% of transferred MHC II+ macrophages became MHC II
and almost 25% of transferred MHC II macrophages were
MHC II+ between days 3 and 10 of STIA. In contrast, when
we sorted and adoptively transferred MHC II+ and MHC II
macrophages from day 7 of STIA and followed them into the
late-resolution phase (day 18), almost 100% of cells became
MHC II (Figures S3G and S3H).
Tissue-Resident Macrophages Attenuate the Severity
of STIA
To understand the roles played by tissue-resident (MHC II)
and bone-marrow-derived (MHC II+) macrophages in the devel-
opment of STIA, we selectively deleted these populations from
the naive joint prior to the development of STIA. To accomplish
this, we took advantage of the CD11b-diphtheria toxin
receptor (DTR) system, in which monocytes and bone-marrow-
derived macrophages express the DTR under the control of
the CD11b promoter. We used these mice to create two groups
of bone marrow chimeras: (1) CD11b-DTR bone marrow596 Cell Reports 9, 591–604, October 23, 2014 ª2014 The Authors(CD11b-DTR/CD45.2) into lethally irradi-
ated CD45.1 recipients (CD11b-DTR/
CD45.1) and (2) by CD45.1 bone
marrow into CD11b-DTR/CD45.2 recipi-
ents (CD45.1/CD11b-DTR). Consistentwith the wild-type chimeras (Figure 2C), more than 80% of the
tissue-resident MHC II macrophages were of recipient origin,
whereas the vast majority of the tissue-resident MHC II+ macro-
phages were derived from the donor bone marrow (Figures 4A
and 4C). We then treated CD11b-DTR/CD45.1 and
CD45.1/CD11b-DTR mice with an intra-articular injection of
low-dose diphtheria toxin (DT), which does not affect the circu-
lating monocyte pool (Figure S4A), and then induced STIA
24 hr later. Loss of MHC II+ macrophages in CD11b-DTR/
CD45.1 mice had no effect (Figure 4B) on the course of
STIA, whereas depletion of tissue-resident MHC II macro-
phages in CD45.1/CD11b-DTR mice led to increased
arthritis (Figure 4D). To explore how tissue-resident macro-
phages might attenuate joint inflammation during STIA, we
examined their phagocytic capacity in vivo. All MHC II macro-
phages phagocytized 2 MDa tetramethylrhodamine (TRITC)-
labeled dextran, whereas only a portion (50%) of MHC II+
macrophages were TRITC positive (Figure 4E). These data
suggest that MHC II tissue-resident macrophages play an
important role in maintaining joint integrity and may limit the
development of arthritis.
Recruited Monocytes and Inflammatory Macrophages
Are Required for the Propagation Phase in STIA
We have shown that nonclassical Ly6C monocytes are essen-
tial for the initiation and propagation of STIA and give rise to
inflammatory macrophages. To investigate the role of these
monocytes and bone-marrow-derived macrophages during the
effector phase of STIA, we depleted them by systemically
administering DT to CD11b-DTR/CD45.1 chimeric mice.
Peripheral blood monocytes and bone-marrow-derived synovial
macrophages were depleted after systemic treatment with DT
(Figures 5A and 5B), whereas host MHC II tissue-resident mac-
rophages (DTR) were insensitive to DT (Figure 5B). When we
repeatedly treated CD11b-DTR/CD45.1 mice DT, the severity
of arthritis as measured by ankle swelling and clinical scores
was markedly decreased as compared to controls. The small
amount of arthritis that developed in the CD11b-DTR/CD45.1
mice was associated with an increased number of neutrophils
in the joint as compared to nonarthritic controls, but not macro-
phages (Figure 5D). Repeated administration of DT prevented
the propagation phase (Figure 5D), which resulted in reduced
histological scores of arthritis (Figures 5F and 5G). Additionally,
the number of stromal (CD45) cells did not change throughout
STIA (Figure 5E). To exclude a requirement for DCs in the devel-
opment of STIA, we generated CD11c-DTR/CD45.1 chimeric
mice and subjected them to repeated administration of DT.
Despite the fact that CD11b+ DCs were deleted (Figure S4B),
DT-treated mice exhibited similar levels of arthritis as compared
to control mice (Figure S4C).
Recruited Tissue Macrophages, but Not Blood
Monocytes, Are Required for the Resolution of STIA
Recent findings suggest that resolution of sterile inflammation
may require recruitment of monocytes into tissues (Nahrendorf
et al., 2007; Soehnlein and Lindbom, 2010). However, when we
depleted blood monocytes at the peak of arthritis using intrave-
nous injection of clodronate-loaded liposomes, the resolution of
arthritis was unchanged (Figure 6A). In contrast, when we
depleted both blood monocytes and recruited macrophages
using systemic treatment of chimeric CD11b-DTR/CD45.1
mice with DT at the peak of arthritis, the resolution of arthritis
was delayed as evidenced by sustained elevations in the histo-
pathological scores for pannus, cartilage destruction, and
bone erosion relative to untreated mice (Figures 6B–6E).
Synovial Macrophages Are Reprogrammed from
Inflammatory toward a Resolution Phenotype
Our data suggest that the same population of macrophages
responsible for the development of arthritis also participated in
its resolution. Macrophages may be polarized to a particular
phenotype that is dependent on the environmental milieu; there-
fore, we examined whether synovial macrophages undergo a
change in phenotype from classically activated M1 macro-
phages that drive destruction of the joint to alternatively
activatedM2macrophages that are necessary for healing. Polar-
ization of synovial macrophages in the naive joint (D0) during the
peak of STIA (D7) and during the resolution phase of STIA (D14)
was assessed on sorted MHC II+ and MHC II synovial macro-
phages, which were analyzed for gene expression using a
custom QuantiGene 2.0 panel (Table S4). Among the 52 genes
included into the panel, 46were differentially expressed between
macrophage subsets according to selected criteria (differentially
expressed in at least one two-group comparison; false discovery
rate [FDR]-corrected q-value < 0.001; Table S5). Principal
component analysis revealed that MHC II and MHC II+ macro-Cphages in the naive joint (D0) clustered separately from each
other along PC2 axis, which is in agreement with differential
origin of these populations (tissue-resident versus bone-
marrow-derived; Figures 7A and 7B). Twenty-three genes were
differentially expressed between MHC II+ and MHC II macro-
phages in the steady state (D0; Table S5), including Timd4, which
is in agreement with data obtained via flow cytometry (Fig-
ure S2A). Further, the MHC II+ and MHC II macrophages re-
cruited into the joint during STIA (D7 and D14) also clustered
together. We then selectively compared the polarization profiles
of synovial macrophages at the peak of STIA and during its res-
olution with MHC II+ D0 macrophages, which are bone-marrow-
derived and, therefore, more closely resemble macrophages
recruited during STIA. At both the peak of STIA (day 7) and during
the resolution of STIA (day 14), both MHC II+ and MHC II mac-
rophages exhibited an enhancedM1 and intermediate M2 polar-
ization profile compared with MHC II+ macrophages at D0.
These changes included increased expression of several M1
genes (Nfkb1, Il1b, Cd80, Il12b, and Fcrg1) and some M2 genes
(Pparg, Tnfsf14, Il1rn, Tgm2, Chi3l3, and Arg1), with reduced
expression of other M2 genes (Timd4, Relma, Irf4, Cd36,
Cxcl13,Ccl17,Shpk,Nr4a1, andMrc1). Interestingly, the expres-
sion ofMertk, which is involved in uptake of apoptotic cells, was
increased in both MHC II+ and MHC II macrophages during the
resolution of STIA, but not at its peak.
We then compared the gene expression of MHC II+ and MHC
II macrophage populations at the peak (D7) of STIA. MHC II+
macrophages expressed more M1-associated genes (Il1b,
Il12b, CD80, and CD86) and someM2-associated genes (Pparg,
Il1rn,Kdm6b, Tnfsf14,Socs1, Il33, andCcl17) compared toMHC
II macrophages. However, the expression of several M2-asso-
ciated genes was increased in the MHC II compared with MHC
II+ macrophages including Timd4, Tfrc, CD36, CD163, Cxcl13,
Mertk, and the hallmark gene of murine M2 activation—Arg1.
The only M1 gene, which was expressed at higher levels in
MHC II macrophages, was Tnf. A similar pattern was observed
during the resolution phase of STIA (D14). Day 14 MHC II+ mac-
rophages expressed more M1 (Il1b, Il6, Il12b, and CD86) and
some M2 genes (Retnla, Pparg, Il1rn, Kdm6b, Tnfsf14, Socs1,
Il33, Ccl17, Irf4, Hbegf, Nr4a1, Il10, and Mrc1) whereas MHC
II macrophages expressed higher levels of M2 genes (Timd4,
CD36,Cxcl13, Tgm2, andArg1). Taken together, these data sug-
gest that both MHC II+ and MHC II macrophages exhibit mixed
M1/M2 polarization during STIA. However, MHC II macro-
phages express more M2 genes throughout the course of
STIA. Because many of the genes differentially expressed in
MHC II macrophages are involved in uptake of apoptotic
bodies and resolution of inflammation, we analyzed expression
of CD36 (Figure 7C), a member of class B scavenger receptor
family involved in the uptake of apoptotic bodies (efferocytosis)
and a marker of alternatively activated macrophages (Xiong
et al., 2013). In agreement with the gene-expression profiles,
we found that only fraction MHC II+ macrophages expressed
CD36 during STIA, unlike MHC II macrophages, which uni-
formly expressed high levels of CD36. Taken together, these
data and the fate-mapping studies suggest that change in
macrophage phenotype during STIA from MHC II+ to MHC II
is associated with transition from M1 to M2 phenotype.ell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 597
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Figure 5. Recruitment of Monocytes and Differentiation into Macrophages Are Required for Development of Joint Pathology during STIA
(A) Systemic treatment with DT eliminated bloodmonocytes while sparing neutrophils. Representative contour plots are shown. Numbers represent percentages
of CD45+ cells.
(B) Systemic treatment with DT eliminates DTR-expressing tissue macrophages (CD45.2) in the synovium of CD11b-DTR(CD45.2)/CD45.1 bone marrow
chimeras. Representative contour plots are shown, and numbers indicate percentages of CD45+ cells.
(C) Repeated administration of DT decreases severity of arthritis (n = 10).
(D) Continuous treatment with DT decreased number of cells recruited to the joint (n = 4 per time point).
(E) Dynamic of myeloid cell subsets in the joints during the course of STIA in PBS and DT-treated mice.
(F) Depletion of tissue macrophages during effector phase of STIA decreases joint damage. Top: hematoxylin and eosin staining (tibiotalar joint is shown); scale
bar represents 100 mm. BM, bone marrow; C, cartilage; H&E, hematoxylin and eosin; JC, joint cavity; P, pannus; SL, synovial lining. Bottom: immunohisto-
chemical staining for macrophage marker F4/80. Arrows indicate F4/80-positive cells. The scale bar represents 20 mm.
(G) Depletion of tissue macrophages decreases histopathological scores. HPVF, high-power view field; PMN, polymorphonuclear neutrophil.
Data are represented asmean ± SEM. Differences between groups were compared using two-way ANOVA for repeatedmeasurements with Bonferroni posttest;
*p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 6. Role of Monocytes and Macrophages in the Resolution of STIA
(A) Depletion of monocytes does not affect resolution of STIA (n = 4).
(B) Depletion of monocytes and tissue macrophages during the resolution phase of STIA delays resolution of arthritis (n = 7).
(C) Repeated administration of DT depletes tissue macrophages.
(D) Repeated administration of DT depletes tissue macrophages: Immunohistochemistry was performed on ankle section for F4/80. The scale bar
represents 50 mm.
(E) Depletion of tissue macrophages during resolution phase results in higher histopathological scores.
Data are represented as mean ± SEM. Differences between groups were compared using two-way ANOVA for repeated measurements with Bonferroni posttest
(arthritis) or with Student’s t test (histopathology); *p < 0.05; **p < 0.01; ***p < 0.001.DISCUSSION
Synovial macrophageswere discoveredmore than half a century
ago and are known to be necessary for the development of
arthritis (Barland et al., 1962); however, little is known about their
origins and roles inmaintenance of the normal joint or in the path-
ogenesis of RA. We used a strategy of depletion and selective
rescue of nonclassical Ly6C monocytes to show they are
both necessary and sufficient for the initiation of STIA. OurCdata show that nonclassical Ly6C monocytes can directly
participate in tissue injury. Furthermore, our data suggest that
the pathogenesis of autoimmune arthritis is distinct from other
forms of tissue injury in which Ly6C+ monocytes are preferen-
tially recruited into inflamed tissues in a CCR2-dependent
manner and give rise to inflammatory macrophages, as has
been described during bacterial infection (Auffray et al., 2007;
Serbina et al., 2003), myocardial infarction (Nahrendorf et al.,
2007), muscle injury (Arnold et al., 2007), and CNS injuryell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 599
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Figure 7. Synovial Macrophages Switch Phenotype during the Course of STIA
(A) Principal-component analysis of gene expression in synovial macrophages confirms the differential origins of MHC II+ and MHC II synovial macrophages in
the steady state.
(B) Hierarchical clustering of 46 genes differentially expressed across the data set (FDR q value < 0.001).
(C) Expression of CD36 on synovial macrophages during the course of STIA and analyzed by flow cytometry. Representative contour plots are shown. Numbers
represent percentages of the parent gate.(Shechter et al., 2013). Our data explain the previous observation
that CCR2/ mice, which have decreased numbers of classical
Ly6C+ monocytes, develop the same magnitude of STIA as con-
trols and have a similar ability to recruit monocytes into the joint.
We describe an approach that can be used to determine whether
nonclassical Ly6Cmonocytes may contribute to tissue injury in
other autoimmune models of inflammation as has been sug-
gested (Mildner et al., 2013; Soehnlein and Lindbom, 2010).
For example, in a model of autoimmune kidney injury, Carlin
et al. (2013) suggested that nonclassical Ly6C monocytes
attract neutrophils in response to TLR7 stimulation and facilitate
their extravasation into the tissue; however, they did not observe
recruitment of nonclassical Ly6C monocytes, possibly due to
the short duration of observation. By selectively labeling only
nonclassical Ly6C monocytes, we were able to demonstrate
that this monocyte subset is recruited into the joint during
STIA, where they give rise to proinflammatory macrophages.
Importantly, our strategy allowed us to follow the recruitment
of nonclassical Ly6C monocytes into the joint in the presence
of classical Ly6C+ monocytes. If a similar distinct role for
nonclassical Ly6C monocytes in the development of autoim-
mune inflammation in other models is confirmed, this would pro-
vide a new paradigm for understanding the molecular basis of
these diseases.
Currently, there are no strategies in mice to selectively
deplete nonclassical Ly6C monocytes; however, their
numbers are reduced in mice with deletions of Cx3cr1,
Nr4a1, or S1pr5 (Debien et al., 2013; Hanna et al., 2011;
Landsman et al., 2009). Whereas the impact of NR4A1 or
S1PR5 deficiency on STIA has not been studied, mice lacking
CX3CR1 have been reported to develop less STIA (Jacobs
et al., 2010). Our data, in which even the adoptive transfer of
a small number of nonclassical Ly6C monocytes was suffi-
cient to induce STIA, highlight the importance of this subset.
Therefore, whereas our study does not dismiss the important
role of neutrophils and classical Ly6C+ monocytes in STIA, it
clearly demonstrates that nonclassical Ly6C monocytes are600 Cell Reports 9, 591–604, October 23, 2014 ª2014 The Authorsboth necessary and sufficient for the initiation and propagation
phases of arthritis.
The cellular composition of various macrophage populations
in the naive and inflamed joint has been largely unexplored.
Flow cytometric analysis extending beyond assessment of
CD11b or Gr-1 expression has only been reported in rats (Mog-
haddami et al., 2005a, 2005b, 2007) or synovial fluid of knee
joints (Bruhns et al., 2003). None of these studies included tech-
niques that determined the origin of synovial macrophages.
Here, we generated bone marrow chimeric mice with selective
shielding of the joint during irradiation to demonstrate that the
naive mouse joint contains a heterogeneous population of mac-
rophages, namely tissue-resident and bone-marrow-derived
macrophages (Ginhoux and Jung, 2014; Hashimoto et al.,
2013; Yona et al., 2013). In the naive joint, the vast majority of
the tissue-resident synovial macrophages are MHC II, whereas
the bone-marrow-derivedmacrophages aremostlyMHC II+. Tis-
sue-resident macrophages populate the synovial tissue early
during embryonic development and are derived from outside of
the bone marrow via a process that requires M-CSF. If M-CSF
is absent during early embryogenesis, the synovium is populated
with bone-marrow-derived macrophages, which may be re-
cruited via interleukin (IL)-34, an alternative ligand for M-CSF-R
(Wei et al., 2010). We found that depletion of tissue-resident
MHC II macrophages results in worsened STIA, suggesting
these cells play an important role in maintaining tissue integrity
and limiting inflammation (Lavin and Merad, 2013). We also
show that tissue-resident macrophages exhibit a low level of
proliferation during steady-state conditions and in inflammation.
This local proliferation likely contributes to maintaining the pop-
ulation of tissue-resident macrophages during steady-state con-
ditions; however, unlike other models of inflammation (Davies
et al., 2011; Jenkins et al., 2011), it does not contribute to the
increased number of synovial macrophages during STIA, a
large majority of which are monocyte derived. This leaves
open the possibility that inefficient repair mediated by tissue-
resident macrophages may play a role in chronic arthritis. Unlike
tissue-resident macrophages, bone-marrow-derived macro-
phages are short lived and require constant influx of monocytes
to maintain their population. Our short-term cell-tracking studies
suggest that bone-marrow-derivedmonocytes do not contribute
to the synovial macrophage population under steady-state con-
ditions. However, in the absence of CCR2, Ly6C+ monocytes
can give rise to Ly6C+CD64int cells, which may differentiate
intomacrophages. The Ly6C+CD64int cells are not depleted after
the systemic administration of clodronate-loaded liposomes,
suggesting these cells may originate from extravasated tissue-
surveying monocytes (Jakubzick et al., 2013).
Recently, macrophage polarization in health and disease has
received a great deal of attention due to the therapeutic potential
of altering macrophage phenotype. Macrophages may be
readily manipulated in vitro to generate distinct classically
activated/M1 or alternatively activated/M2 cells (Mosser and
Edwards, 2008); however, their phenotypes in vivo may not be
as straightforward (Sica and Mantovani, 2012; Xue et al.,
2014). M1/M2 activation of synovial macrophages in STIA was
dramatically different from M1 and M2 phenotypes obtained
in vitro using lipopolysaccharide/interferon-g or IL-4, corre-
spondingly (data not shown). For example, inducible nitric oxide
synthase, a hallmark of in vitro M1 activation, is not elevated at
the peak of STIA. Similarly, Mrc1 (CD206), Retnla (RELMa),
and Chi3l3 (Ym1) are not upregulated during the resolution
phase. Instead, the resolution phase of STIA is associated with
increased expression of genes involved in uptake of apoptotic
debris and processing lipids, such as Pparg (PPARg), Mertk
(MerTK), Tgm2 (Tgm2), and Cd36 (CD36). The fact that subpop-
ulations of synovial macrophages during the steady state and
STIA exhibit mixed M1/M2 activation and differential expression
of CD36may suggest they aremore heterogeneous than our cur-
rent grouping based on expression of MHC II. Importantly, our
findings of macrophage heterogeneity in mice are relevant to
humans, as we observed a similar phenomenon using synovial
biopsies from healthy volunteers and patients with RA. New
technologies, such as parallel single-cell RNA sequencing (Jaitin
et al., 2014), have the potential to allow unbiased analysis of the
change in macrophage phenotype using animal models of RA
and synovial tissue.
Whereas our labeling studies indicate that monocyte recruit-
ment into the joints is continuous through all the phases of
STIA, selective depletion of blood monocytes versus recruited
macrophages confirms that the recruited macrophages are
necessary for the resolution of arthritis and healing of the joint.
These data show that the same classically activated macro-
phages recruited during the development of STIA phase switch
their phenotype and become wound healing macrophages,
and unlike in other models of inflammation, this process does
not require the entrance of a second wave of monocytes into
the tissue (Arnold et al., 2007; Nahrendorf et al., 2007; Shechter
et al., 2009). This change in macrophage phenotype coincides
with an upregulation of the molecules involved in efferocytosis
and the rapid decrease in neutrophils from the joint, suggesting
that apoptotic neutrophils into the joint during STIA may drive re-
cruited macrophages toward a more M2 phenotype. This hy-
pothesis is supported by findings in other models of tissue injury
(Korns et al., 2011; Soehnlein and Lindbom, 2010). Whereas theCsystemic injection of apoptotic cells is not sufficient to prevent
STIA (Gray et al., 2007), it is possible that phagocytosis of the
apoptotic cells in the synovium may be more important for
altering synovial macrophage phenotype than efferocytosis of
apoptotic cells in the circulation. Consistent with this hypothesis,
classically activated M1 macrophages recruited during early
stages of STIA-mediated inflammation may efficiently clear
apoptotic neutrophils (Korns et al., 2011).
In summary, we have identified a previously unrecognized role
for nonclassical Ly6C monocytes and tissue-resident macro-
phages in the development of autoimmune arthritis. Our data
support a model in which Ly6C nonclassical monocytes are re-
cruited to the joint during inflammation, where they are both
required and sufficient for the development of arthritis. Over
the course of STIA, these same recruited macrophages undergo
a remarkable change in their pattern of gene expression, initially
expressing a complex set of both M1 and M2 genes followed by
a shift toward a more M2 phenotype. This change in gene
expression is accompanied by an alteration in function, as deple-
tion of these macrophages at the peak of arthritis slows arthritis
resolution. Throughout the course of STIA, tissue-resident syno-
vial macrophages remain polarized toward a M2 phenotype and
attenuate the severity of arthritis; however, their protective sig-
nals are likely overwhelmed by a relatively large influx of nonclas-
sical monocytes from the circulation. Whether this mechanism
may be generalized to other forms of autoimmune inflammation
in other tissues warrants further investigation. The approach
we have developed demonstrates how a better longitudinal
understanding of the roles of individual subsets of monocytes,
tissue macrophages, and neutrophils over the course of inflam-
mation and its resolution can pave the way for improved strate-
gies for targeting mononuclear phagocytes in autoimmune
inflammation.EXPERIMENTAL PROCEDURES
Mice
The following mouse strains were used: C57Bl/6, B6.SJL-Ptprca Pepcb/
BoyJ (CD45.1), CCR2/, Cx3cr1gfp/+ (Jung et al., 2000), B6.Cg-Gt(ROSA)
26Sortm6(CAG-ZsGreen1)Hze/J; B6;C3Fe a/a-Csf1op/J (Csf1op), B6.FVB-Tg
(ITGAM-DTR/EGFP)34Lan/J (CD11b-DTR), and B6.FVB-Tg(Itgax-DTR/
EGFP)57Lan/J (CD11c-DTR). All mice were purchased from the Jackson Lab-
oratory and bred and housed at a barrier and specific pathogen-free facility at
the Center for ComparativeMedicine at Northwestern University. Eight- to ten-
week-old mice were used for all experiments. All procedures were approved
by the Institutional Animal Care and Use committee at Northwestern Univer-
sity. Generation of CD11b-DTR andCD11c-DTR bonemarrow chimeras, diph-
theria toxin treatment, and monocyte depletion are described in Supplemental
Experimental Procedures.
K/BxN Serum-Transfer-Induced Arthritis
Serum transfer arthritis was induced by intravenous injection of 75 ml of arthri-
togenic serum from 8-week-old progeny of KRN and nonobese diabetic (NOD)
mice (K/BxN) mice (Monach et al., 2008). Change in ankle thickness wasmoni-
tored using caliper (Fowler Tools of Canada). In addition, clinical score was
assessed as a sum of the clinical score for each paw (0, no arthritis; 1, mild
arthritis, foot maintains V-shape; 2, moderate arthritis, foot no longer maintains
V-shape; 3, severe arthritis). Each experiment was performed two to five times
to confirm reproducibility. Whenever possible, scoring was performed in a
blinded manner. Histological and histopathological assessment of arthritis is
described in Supplemental Experimental Procedures.ell Reports 9, 591–604, October 23, 2014 ª2014 The Authors 601
Tissue Preparation and Flow Cytometry
Blood was collected into EDTA-containing tubes either via facial vein bleed
(from live animals) or via cardiac puncture (from euthanized animals). Whole
bloodwas stainedwith fluorochrome-conjugated antibodies, and erythrocytes
were then lysed using BD FACS lysing solution (BD Biosciences). Spleen was
digested using mixture of Collagenase D and DNase I (both from Roche) in
Hank’s balanced salt solution (HBSS) at 37C for 30 min and filtered through
40 mm nylon mesh. Erythrocytes were lysed using BD Pharm Lyse (BD
Biosciences), and cells were counted using Countess automated cell counter
(Invitrogen); dead cells were discriminated using trypan blue. For ankle
analysis, mice were perfused through the left ventricle with 20 ml of HBSS.
Ankles were cut 3 mm above the heel, and skin from the feet was removed.
To avoid contamination with the bone marrow, bone marrow cavity in the tibia
was thoroughly flushed with HBSS, fingers were disarticulated by pulling with
blunt forceps, and tibiotalar joint was opened via posterior access route to
expose synovial lining. The foot was incubated in digestion buffer (2mg/ml dis-
pase II, 2 mg/ml collagenase D, and 1 mg/ml of DNase I in HBSS) for 60 min at
37C. Cells released during the digestion were filtered through 40 mm nylon
mesh, erythrocytes were lysed using BD Pharm Lyse (BD Biosciences), and
cells were counted using Countess automated cell counter (Invitrogen); dead
cells were discriminated using trypan blue. Cells were stained with live/dead
Aqua (Invitrogen) or eFluor 506 (eBioscience) viability dyes, incubated with
FcBlock (BD Bioscience), and stained with fluorochrome-conjugated anti-
bodies (see Table S1 for the list of antibodies, clones, fluorochromes, and
manufacturers). Data were acquired on BD LSR II flow cytometer (BD Biosci-
ences; see Table S2 for instrument configuration). Compensation and analysis
of the flow cytometry data were performed using FlowJo software (Tree Star).
‘‘Fluorescence minus one’’ controls were used when necessary to set up
gates. Expression of the activationmarkers presented asmedian fluorescence
intensity. Click-iT EdU Kit (Invitrogen) was used to assess the macrophage
proliferation. Cell sorting was performed at University of Chicago Flow Cytom-
etry core facility and at Northwestern University Robert H. Lurie Comprehen-
sive Cancer Center Flow Cytometry core facility on FACSAria III instrument
(BD Biosciences) with the same configuration as LSR II. Cytospins were
prepared from sorted cells and stained with Diff-Quik Stain Set (Siemens
Healthcare). Microphotographs of the individual representative cells were
taken on Nikon Eclipse TE2000E2 microscope, and representative images of
the individual cells were combined into one panel using Adobe Photoshop
without any additional manipulations.
Analysis of Macrophage Polarization
Synovial macrophages from steady-state or STIA ankles were sorted using
FACSAria III instrument, washed once, and cell pellets were lysed directly in
QuantiGene Cell Lysis Mixture. Gene-expression profiles were determined us-
ing custom QuantiGene 2.0 assay (panel no. 21522; Affymetrix) on Luminex
200 instrument (Luminex); see Table S4 for the panel description. Data were
normalized to expression of housekeeping genes and imported into Partek
Genomics Suite V6.6 software (Partek). Differentially expressed genes be-
tween the different groups of macrophages as well as transcripts with variable
expression within the data set were calculated using one-way ANOVA. Differ-
entially expressed genes were defined by a fold change greater than 1.4 and a
FDR-corrected q-value < 0.001 unless stated otherwise. Principle-component
analysis using all transcripts was used for visualization of sample relationships.
Hierarchical clustering of the differentially expressed genes was performed
based on Euclidean algorithm for dissimilarity and average linkage method
to determine distance between clusters.
Statistical Analysis
In arthritis experiments, differences in ankle width and clinical score between
the groups were assessed using two-way ANOVA for repeated measurements
with Bonferroni posttest to compare differences between the groups. For his-
topathological scores, differences between groups were determined using
Student’s t tests. All analyses were performed using GraphPad Prism version
5.00 (GraphPad Software). Data are shown as means ± SEM unless stated
otherwise.
Additional materials and methods can be found in Supplemental
Information.602 Cell Reports 9, 591–604, October 23, 2014 ª2014 The AuthorsSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.09.032.
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